Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Phase II Study of Ficlatuzumab With or Without Cetuximab in Patients With Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

NCT03422536 is registered in ClinicalTrials.gov with University of Arizona as lead sponsor.

NCT NCT03422536
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03422536 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Phase II Study of Ficlatuzumab With or Without Cetuximab in Patients With Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Lead sponsor
University of Arizona
Phase
Phase 2
Overall status
Completed
Start date
December 5, 2017
Completion date
April 5, 2022
Enrollment
78 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck basaloid carcinoma, head and neck cancer, hnscc, oropharyngeal cancer, recurrent head and neck squamous cell carcinoma, recurrent oropharyngeal squamous cell carcinoma, squamous cell carcinoma of unknown primary origin, stage iv lip and oral cavity squamous cell carcinoma, stage iv nasopharyngeal keratinizing squamous cell carcinoma, stage iv oropharyngeal squamous cell carcinoma, stage iv squamous cell carcinoma of the lip and oral cavity, stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity, stage iva lip and oral cavity squamous cell carcinoma, stage iva nasal cavity and paranasal sinus squamous cell carcinoma, stage iva nasopharyngeal keratinizing squamous cell carcinoma, stage iva oropharyngeal squamous cell carcinoma, stage ivb lip and oral cavity squamous cell carcinoma, stage ivb nasal cavity and paranasal sinus squamous cell carcinoma, stage ivb nasopharyngeal keratinizing squamous cell carcinoma, stage ivb oropharyngeal squamous cell carcinoma, stage ivc lip and oral cavity squamous cell carcinoma, stage ivc nasal cavity and paranasal sinus squamous cell carcinoma, stage ivc nasopharyngeal keratinizing squamous cell carcinoma, stage ivc oropharyngeal squamous cell carcinoma